Integer (NYSE:ITGR) Price Target Lowered to $147.00 at Truist Financial

Integer (NYSE:ITGR) had its price objective trimmed by Truist Financial from $150.00 to $147.00 in a research note released on Friday morning, Benzinga reports. The brokerage currently has a buy rating on the medical equipment provider’s stock.

Several other equities research analysts have also weighed in on the company. Oppenheimer began coverage on Integer in a research report on Tuesday, July 16th. They issued an “outperform” rating and a $135.00 target price on the stock. Bank of America lifted their price objective on shares of Integer from $135.00 to $145.00 and gave the company a “buy” rating in a research report on Tuesday, October 1st. KeyCorp upped their target price on shares of Integer from $139.00 to $144.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 15th. Citigroup lifted their price target on Integer from $124.00 to $130.00 and gave the company a “neutral” rating in a report on Tuesday, October 1st. Finally, Benchmark increased their price objective on Integer from $130.00 to $140.00 and gave the stock a “buy” rating in a report on Monday, October 21st. One equities research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $139.75.

Integer Stock Up 1.8 %

Shares of NYSE:ITGR opened at $128.04 on Friday. The company’s fifty day moving average is $127.69 and its two-hundred day moving average is $121.11. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.96 and a current ratio of 3.29. Integer has a 1-year low of $79.23 and a 1-year high of $133.53. The stock has a market capitalization of $4.29 billion, a price-to-earnings ratio of 44.30, a price-to-earnings-growth ratio of 1.80 and a beta of 1.08.

Integer (NYSE:ITGR) last released its quarterly earnings data on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share for the quarter, topping the consensus estimate of $1.36 by $0.07. Integer had a net margin of 6.31% and a return on equity of 11.48%. The firm had revenue of $431.42 million for the quarter, compared to analyst estimates of $440.59 million. During the same quarter in the prior year, the business earned $1.27 earnings per share. Integer’s quarterly revenue was up 8.7% on a year-over-year basis. Equities analysts anticipate that Integer will post 5.3 EPS for the current year.

Insiders Place Their Bets

In other news, Director Jean M. Hobby sold 11,960 shares of the business’s stock in a transaction on Wednesday, July 31st. The stock was sold at an average price of $119.66, for a total value of $1,431,133.60. Following the sale, the director now owns 2,280 shares of the company’s stock, valued at approximately $272,824.80. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 2.00% of the stock is currently owned by insiders.

Institutional Trading of Integer

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. New York State Common Retirement Fund grew its position in Integer by 1.0% in the third quarter. New York State Common Retirement Fund now owns 192,411 shares of the medical equipment provider’s stock worth $25,013,000 after buying an additional 1,820 shares during the last quarter. Congress Asset Management Co. grew its holdings in shares of Integer by 3.9% in the 3rd quarter. Congress Asset Management Co. now owns 488,785 shares of the medical equipment provider’s stock worth $63,542,000 after acquiring an additional 18,303 shares during the last quarter. First Trust Direct Indexing L.P. acquired a new stake in shares of Integer during the third quarter worth $215,000. OLD National Bancorp IN lifted its holdings in shares of Integer by 10.9% during the third quarter. OLD National Bancorp IN now owns 2,375 shares of the medical equipment provider’s stock valued at $309,000 after purchasing an additional 234 shares during the last quarter. Finally, Waypoint Capital Advisors LLC acquired a new position in shares of Integer in the 3rd quarter valued at $246,000. 99.29% of the stock is currently owned by institutional investors.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.